Helvenstein, M., Hambye, S., & Blankert, B. (04 April 2017). Hepatocyte-based flow analytical bioreactor for online xenobiotics metabolism bioprediction. Nanobiomedicine, 4, 1-11.  Peer reviewed vérifié par ORBi |
  | Helvenstein, M., Stanicki, D., Laurent, S., & Blankert, B. (2015). Interaction between iron oxide nanoparticles and HepaRG cells: a preliminary In vitro evaluation. Journal of Nanomaterials. doi:10.1155/2015/463841 Peer reviewed vérifié par ORBi |
Helvenstein, M. (2015). 'Bioréacteur à base de cellules magnétiquement marquées pour l'étude de la biotransformation de substances d'intérêt pharmaceutique : développement et évaluation.' [Doctoral thesis, Université de Mons]. ORBi UMONS-University of Mons. https://orbi.umons.ac.be/handle/20.500.12907/14942 |
Fouad, M., Helvenstein, M., & Blankert, B. (2015). Ultra High Performance Liquid Chromatography Method for the Determination of Two Recently FDA Approved TKIs in Human Plasma Using Diode Array Detection. Journal of Analytical Methods in Chemistry. doi:10.1155/2015/215128 Peer reviewed vérifié par ORBi |
Helvenstein, M., Hambye, S., & Blankert, B. (15 March 2015). Determination of three tyrosine kinase inhibitors and one active metabolite by a validated UPLC-DAD method in human plasma [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Hambye, S., Helvenstein, M., Vanden Eynde, J. J., & Blankert, B. (15 March 2015). First UPLC-Fluo/PDA quantification method of pentamidine and a new promising analogue in biological fluids [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Helvenstein, M., Fouad, M., & Blankert, B. (15 March 2015). Development and validation of UPLC-DAD method for the determination of two recently FDA approved TKIs in human plasma for therapeutic drug monitoring [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Romoaldo, G., Helvenstein, M., Hambye, S., & Blankert, B. (15 March 2015). Identification et quantification de biomarqueurs d'états émotionnels [Poster presentation]. 8ème édition de la Matinée des Chercheurs 2015 (MdC2015), Mons, Belgium. |
Helvenstein, M., Hambye, S., & Blankert, B. (07 July 2014). Determination of three tyrosine kinase inhibitors and one active metabolite by an identical and validated ultra-performance liquid chromatography-DAD method in human plasma. Current Pharmaceutical Analysis, 10, 161-168. Peer reviewed vérifié par ORBi |
Hambye, S., Helvenstein, M., Vanden Eynde, J.-J., & Blankert, B. (23 June 2014). First UPLC-Fluo/PDA quantification method of Pentamidine and a new promising analogue in biological fluids [Poster presentation]. Drug Analysis, Liège, Belgium. |
Nachtergael, A., Coulembier, O., Dubois, P., Helvenstein, M., Duez, P., Blankert, B., & Mespouille, L. (22 June 2014). Organocatalysis paradigm revised: are metal-free catalysts really harmless? [Poster presentation]. Drug Analysis, Liège, Belgium. |
Helvenstein, M., Stanicki, D., & Blankert, B. (22 June 2014). In vitro evaluation of the interaction of iron oxide nanoparticles with the HepaRG cells [Poster presentation]. Drug Analysis, Liège, Belgium. |
Helvenstein, M., Hambye, S., & Blankert, B. (22 June 2014). Determination of three tyrosine kinase inhibitors and one active metabolite by a validated UPLC-DAD method in human plasma [Poster presentation]. Drug Analysis, Liège, Belgium. |
  | Helvenstein, M., Hambye, S., & Blankert, B. (13 February 2014). UPLC-DAD method validation by accuracy profiles approach of tyrosine kinase inhibitors in human plasma [Poster presentation]. 6ème Journée Scientifique du Pôle hainuyer, Mons, Belgium. |
Hambye, S., Helvenstein, M., Verdy, L., Kahvecioglu, Z. C., Conotte, R., Vanden Eynde, J.-J., Colet, J.-M., & Blankert, B. (10 February 2014). Ultra High Performance Liquid Chromatography method for the determination of Pentamidine and analog in rat biological fluids. Journal of Pharmaceutical and Biomedical Analysis, 95, 54-60. Peer reviewed vérifié par ORBi |
Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (29 October 2013). A similar UPLC-UV method for three tyrosine kinase inhibitors determination in human plasma [Paper presentation]. 17th Forum of Pharmaceutical Sciences, Spa, Belgium. |
 | Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (30 June 2013). Ultra-performance liquid chromatography method for the determination of tyrosine kinase inhibitors in human plasma [Poster presentation]. 24th International Symposium on Pharmaceutical and Biomedical Analysis, Bologne, Italy. |
Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (24 May 2013). Tyrosine kinase inhibitors quantification by UPLC-UV in human plasma [Poster presentation]. Health Institute Day, Mons, Umons, Belgium. |
Hambye, S., Ansseau, E., Helvenstein, M., Carminati, A., Vanden Eynde, J.-J., Belayew, A., & Blankert, B. (12 March 2013). Analytical developments and biological evaluation (in Steinert desease) of Pentamidine and new analogs [Poster presentation]. 7ième Matinée des Chercheurs, Mons, Belgium. |
 | Helvenstein, M., Conotte, R., Colet, J.-M., & Blankert, B. (12 March 2013). Tyrosine kinase inhibitors quantification in human plasma [Poster presentation]. 7ième Matinée des Chercheurs, Mons, Belgium. |
Lenaerts, C., Helvenstein, M., & Blankert, B. (29 January 2013). Marinobufagenin and its applications in the diagnosis of preeclampsia [Poster presentation]. Journée scientifique des doctorants en Sciences Biomédicales et Pharmaceutiques: 'New tools and strategies in identification of pathology-related biomarkers', UMONS, Belgium. |